Clinical Trial Units
At any one time the University of Oxford sponsors around 1,000 academic designed and led clinical research studies within the EU of which about 150 are interventional trials ranging from phase I to phase IV. The University sponsors approximately 350 further studies outside the EU, largely through its Centre for Tropical Medicine and Global Health.
Our Clinical Trial Units
We run five UKCRC fully-registered specialist clinical trials units, supporting national, multinational and multicentre trials, ranging from phase I to phase IV.
Clinical Trial Management
Careers in clinical trial management, details of training and development courses and guidance for anyone interested in pursuing a career in trial management.
Participate in a Clinical Trial
If you are interested in participating in a clinical trial, this page contains links to Clinical Trial Units across the University and NHS that maybe recruiting participants.
Latest Clinical Trial News
Celebrating innovation: the PRINCIPLE-PANORAMIC Celebratory Symposium and art exhibition
17 April 2024
Researchers, clinicians, supporters and PPI contributors gathered at the symposium to celebrate the innovative PRINCIPLE and PANORAMIC clinical trials that evaluated potential treatments for COVID-19 during the pandemic and broke recruitment records for community-based trials in doing so. Both trials were run by the Clinical Trails Unit (CTU) in Nuffield Department of Primary Care Health Sciences.
Celebrating collaboration and resilience: The PRINCIPLE PANORAMIC art exhibition
21 March 2024
Celebrate the resilience and collaboration behind Oxford's groundbreaking PANORAMIC and PRINCIPLE COVID-19 trials through "The PANORAMIC PRINCIPLE" exhibition. Artist Tanya Poole's powerful portraits honour the diverse array of participants, researchers, and medical professionals whose inclusive efforts set global benchmarks and transformed lives. An inspiring tribute to human determination in the face of adversity.
New phase 3 trial data confirm the uniquely high efficacy and good safety profile of the R21/Matrix-M malaria vaccine in African children
1 February 2024
Investigators immunised over 4800 young children in a trial in Burkina Faso, Kenya, Mali and Tanzania and found on average 78% efficacy in the 5–17-month age group over the first year To date 25 million doses manufactured and ready for roll-out by The Serum Institute of India (SII) in the next three to four months